In JAMA Oncology Publication, GeneDx Describes Lower Lifetime Risk of Gastric Cancer Conferred by CDH1
A study by GeneDx shows that the lifetime risk for gastric cancer in people with pathogenic CDH1 variants is 42% for men... Read More
Greater Awareness Needed of Stomach Cancer Risk in Under-40s, Especially in Latin America
A study from Mexico found that one in seven people diagnosed with gastric cancer were under 40 and over half were women,... Read More
Women more prone to selected oesophagogastric cancer chemotherapy side-effects
New research presented at ESMO investigates whether men and women should be treated differently in cancer care, finding women are more prone... Read More